APA (7th ed.) Citation

Gettinger, S. N., Song, Z., Reckamp, K. L., Moscow, J. A., Gray, R. J., Wang, V., . . . Flaherty, K. T. (2024). Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A. JCO Precision Oncology, 8, 1. https://doi.org/10.1200/PO.23.00725

Chicago Style (17th ed.) Citation

Gettinger, Scott N., et al. "Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A." JCO Precision Oncology 8 (2024): 1. https://doi.org/10.1200/PO.23.00725.

MLA (9th ed.) Citation

Gettinger, Scott N., et al. "Phase II Trial of Afatinib in Patients With EGFR -Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A." JCO Precision Oncology, vol. 8, 2024, p. 1, https://doi.org/10.1200/PO.23.00725.